Royal Adelaide Hospital
- Country
- 🇦🇺Australia
- Ownership
- Holding
- Established
- 1840-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.rah.sa.gov.au
Clinical Trials
125
Trial Phases
5 Phases
Drug Approvals
1
Drug Approvals
LYMPH-FLO Kit for preparation of Technetium [99mTc] Colloidal Antimony Sulphide Injection, composite pack (68438)
- Product Name
- LYMPH-FLO injection composite pack
- Approval Date
- May 25, 1999
Clinical Trials
Distribution across different clinical trial phases (107 trials with phase data)• Click on a phase to view related trials
Effects of Water and Glucose Drinks on Cardiovascular Function in Subjects With and Without Postprandial Hypotension
- Conditions
- Blood PressureBaroreflex FailureAutonomic Nervous System DiseasesHypotension
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2016-03-18
- Lead Sponsor
- Royal Adelaide Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT02713412
Intraperitoneal Local Anaesthetic in Bowel Surgery
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Royal Adelaide Hospital
- Target Recruit Count
- 86
- Registration Number
- NCT02449720
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2017-07-07
- Lead Sponsor
- Royal Adelaide Hospital
- Target Recruit Count
- 14
- Registration Number
- NCT02324010
- Locations
- 🇦🇺
University of Adelaide, Discipline of Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Royal Adelaide Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02308254
- Locations
- 🇦🇺
Discipline of Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
- First Posted Date
- 2007-07-16
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Royal Adelaide Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT00501657
- Locations
- 🇦🇺
Discipline of Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia
- Prev
- 1
- 2
- Next
News
Aethlon Medical Advances Hemopurifier Cancer Trial with First Three Patients Treated and Indian Regulatory Approval
Aethlon Medical successfully treated the first three patients in its Hemopurifier cancer trial at Australian hospitals, with all participants completing 4-hour treatments without device deficiencies or immediate complications.
Aethlon Medical Advances Hemopurifier Cancer Trial with Second Patient Treatment in Australia
Aethlon Medical successfully treated a second patient with its investigational Hemopurifier device in an Australian clinical trial targeting solid tumors resistant to anti-PD-1 therapies.